PTC Therapeutics Inc., a South Plainfield-based biopharmaceutical company, cut the ribbon on its new Hopewell Township gene therapy manufacturing facility Thursday, October 14. The site is the former BMS site on Pennington-Rocky Hill Road.
The new facility includes about 220,500 square feet of office, manufacturing and laboratory space featuring state-of-the-art technology, the company said in a news release. The new site brings PTC’s New Jersey workforce to 625.
“We are committed to being an innovation-based company that brings the best therapies to patients with rare diseases,” CEO Stuart W. Peltz said in a prepared statement. “Gene therapy holds tremendous promise to treat intractable rare genetic disorders. We have built our capabilities to both perform gene therapy research and to manufacture these biological products.
“We are proud to have such a talented team and state-of-the-art manufacturing facility here in Hopewell that will help expedite bringing these therapies to patients.”
Among the attendees at the ribbon cutting event were US Representative Bonnie Watson-Coleman, Hopewell Township’s Mayor Julie Blake, Deputy Mayor Courtney Peters-Manning, and Committee members Kevin Kuchinski and Kristin McLaughlin.
Peters-Manning said: Hopewell Township is thrilled to have PTC Therapeutics at the Innovation West Campus. Their presence here not only helps Township taxpayers, but their work on rare diseases changes lives for the better every day. We could not have asked for a better partner at the state-of-the-art biotech facility that we are fortunate enough to have here.”
Blake added: “We welcome PTC Therapeutics to Hopewell Township. Their mission, to find cures for rare diseases, provides hope to everyone.”
